Skip to main content

Depression

Patients with depression are less likely to receive guideline-concordant outpatient depression treatment if they have co-occurring substance use disorder, researchers found in a study published online in The American Journal of Psychiatry.
Doses of psilocybin, provided in combination with supporting psychotherapy, was found to produce significant reductions in symptoms of major depression in a study conducted by researchers at Johns Hopkins University.
Students diagnosed with depression undergo a drop in educational performance around ages 15 and 16 years, and boys and students from deprived backgrounds may be especially vulnerable, a study shows.
While social media was rewarding to many users looking for informational, emotional, and peer support when the COVID-19 pandemic hit, excessive use led to mental health issues, according to a study published in Computers in Human Behavior.
Zuranolone, an investigational neuroactive steroid, improved depressive symptoms in a majority of patients within a 14-day treatment course, topline results from an ongoing phase 3 open-label study show.
Back to Top